PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Unit of Neurology, IRCCS Neuromed, Pozzilli (Is), Italy.\', \'Unit of Neurology, IRCCS Neuromed, Pozzilli (Is), Italy; Synaptic Immunopathology Lab, Department of Systems Medicine, Tor Vergata University, Via Montpellier, 1, Rome 00133, Italy.\', \'Unit of Neurology, IRCCS Neuromed, Pozzilli (Is), Italy; NEUROFARBA Department, Florence University, Italy.\', \'Unit of Neurology, IRCCS Neuromed, Pozzilli (Is), Italy; Synaptic Immunopathology Lab, Department of Systems Medicine, Tor Vergata University, Via Montpellier, 1, Rome 00133, Italy. Electronic address: centonze@uniroma2.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2211-0348(21)00250-910.1016/j.msard.2021.102983
?:hasPublicationType
?:journal
  • Multiple sclerosis and related disorders
is ?:pmid of
?:pmid
?:pmid
  • 33990054
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.123
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all